Stay updated on Pembrolizumab in 1st Line NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in 1st Line NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab in 1st Line NSCLC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page's revision tag was updated to v3.6.6, signaling a minor maintenance update to the record. No substantive information about the study is changed.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedA new revision tag 'Revision: v3.6.5' has been added, replacing 'Revision: v3.6.4'. This indicates an updated revision history for the page.SummaryDifference0.0%

- Check46 days agoChange DetectedRevision: v3.6.4 replaces the previous Revision: v3.6.3, indicating a recent update to the page’s content or functionality.SummaryDifference0.0%

- Check67 days agoChange DetectedAdded Revision: v3.6.3 and removed Revision: v3.6.2, signaling a new page release. This appears to be a minor metadata/update rather than content changes to the study details.SummaryDifference0.0%

- Check74 days agoChange DetectedThe page shows Revision: v3.6.2, replacing the previous Revision: v3.6.0 tag as part of a platform revision update.SummaryDifference0.0%

- Check88 days agoChange DetectedThe page now shows a recruitment status note ('No longer looking for participants') and adds new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) along with an updated Intervention/Treatment section and a Revision: v3.6.0. The previous label 'Intervention / Treatment' has been replaced with 'Intervention/Treatment' and the older 'Revision: v3.5.5' tag was removed.SummaryDifference0.3%

Stay in the know with updates to Pembrolizumab in 1st Line NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in 1st Line NSCLC Clinical Trial page.